Bayesian multiple imputation for missing multivariate longitudinal data from a Parkinson's disease clinical trial
暂无分享,去创建一个
Andrew B Lawson | Jordan J Elm | Barbara C Tilley | A. Lawson | S. Luo | B. Tilley | J. Elm | Sheng Luo | Bo He | Bo He
[1] M. R. Novick,et al. Statistical Theories of Mental Test Scores. , 1971 .
[2] Z. Schwab,et al. Projection technique for evaluating surgery in Parkinson’s disease , 1969 .
[3] F. Lord. Applications of Item Response Theory To Practical Testing Problems , 1980 .
[4] P. O'Brien. Procedures for comparing samples with multiple endpoints. , 1984, Biometrics.
[5] T. W. Anderson,et al. An Introduction to Multivariate Statistical Analysis , 1959 .
[6] N L Geller,et al. The analysis of multiple endpoints in clinical trials. , 1987, Biometrics.
[7] D. Rubin,et al. Statistical Analysis with Missing Data. , 1989 .
[8] R. Bloch,et al. Interobserver agreement for the assessment of handicap in stroke patients. , 1988, Stroke.
[9] Nancy L. Geller,et al. An approximate likelihood ratio test for a normal mean vector with nonnegative components with application to clinical trials , 1989 .
[10] G Wassmer,et al. Procedures for two-sample comparisons with multiple endpoints controlling the experimentwise error rate. , 1991, Biometrics.
[11] D I Tang,et al. On the design and analysis of randomized clinical trials with multiple endpoints. , 1993, Biometrics.
[12] L Hothorn,et al. Multiple comparisons in long-term toxicity studies. , 1994, Environmental health perspectives.
[13] S. Medendorp,et al. Low‐dose (7.5 mg) oral methotrexate reduces the rate of progression in chronic progressive multiple sclerosis , 1995, Annals of neurology.
[14] R Little,et al. Intent-to-treat analysis for longitudinal studies with drop-outs. , 1996, Biometrics.
[15] N L Geller,et al. Use of a global test for multiple outcomes in stroke trials with application to the National Institute of Neurological Disorders and Stroke t-PA Stroke Trial. , 1996, Stroke.
[16] Dei-In Tang,et al. An Approximate Likelihood Ratio Test for Comparing Several Treatments to a Control , 1997 .
[17] F. Samejima. Graded Response Model , 1997 .
[18] S. Pocock. Clinical trials with multiple outcomes: a statistical perspective on their design, analysis, and interpretation. , 1997, Controlled clinical trials.
[19] S. Janson,et al. Clinical differences among women with and without self-reported perimenstrual asthma. , 1998, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[20] I. Shoulson. DATATOP: a decade of neuroprotective inquiry. Parkinson Study Group. Deprenyl And Tocopherol Antioxidative Therapy Of Parkinsonism. , 1998, Annals of neurology.
[21] Ira Shoulson,et al. DATATOP: A decade of neuroprotective inquiry , 1998 .
[22] D I Tang,et al. Closed Testing Procedures for Group Sequential Clinical Trials with Multiple Endpoints , 1999, Biometrics.
[23] M. Lezak,et al. Neuropsychological impairment in amateur soccer players. , 1999, JAMA.
[24] C Trenkwalder,et al. A randomized controlled study of pergolide in patients with restless legs syndrome , 1999, Neurology.
[25] Joseph P. Broderick,et al. Effects of tissue plasminogen activator for acute ischemic stroke at one year , 1999 .
[26] J. Douglas. Item response models for longitudinal quality of life data in clinical trials. , 1999, Statistics in medicine.
[27] M. van Kleef,et al. Randomized trial of radiofrequency lumbar facet denervation for chronic low back pain. , 1999, Spine.
[28] David E. Booth,et al. Analysis of Incomplete Multivariate Data , 2000, Technometrics.
[29] Andrew Thomas,et al. WinBUGS - A Bayesian modelling framework: Concepts, structure, and extensibility , 2000, Stat. Comput..
[30] D. Li,et al. Randomized controlled trial of interferon-beta-1a in secondary progressive MS: MRI results , 2001 .
[31] H. Glick,et al. Preference-based quality-of-life in patients with Parkinson’s disease , 2002, Neurology.
[32] Bhushan Kumar,et al. Minoxidil vs finasteride in the treatment of men with androgenetic alopecia. , 2003, Archives of dermatology.
[33] Nicole A. Lazar,et al. Statistical Analysis With Missing Data , 2003, Technometrics.
[34] T. Karrison,et al. A Rank-Sum-Type Test for Paired Data with Multiple Endpoints , 2004 .
[35] Garrett M. Fitzmaurice,et al. Analysis of longitudinal multiple‐source binary data using generalized estimating equations , 2004 .
[36] Mona L. Martin,et al. Quality of life and parkinson's disease: Translation and validation of the US Parkinson's Disease Questionnaire (PDQ-39) , 1999, Quality of Life Research.
[37] Anja Vogler,et al. An Introduction to Multivariate Statistical Analysis , 2004 .
[38] S. Lipsitz,et al. Missing-Data Methods for Generalized Linear Models , 2005 .
[39] D. Andrade,et al. Item response theory for longitudinal data: population parameter estimation , 2005 .
[40] Stuart Lipsitz,et al. Adjusting O'Brien's Test to Control Type I Error for the Generalized Nonparametric Behrens–Fisher Problem , 2005, Biometrics.
[41] Houeto Jean-Luc. [Parkinson's disease]. , 2022, La Revue du praticien.
[42] Stan Lipovetsky,et al. Generalized Latent Variable Modeling: Multilevel,Longitudinal, and Structural Equation Models , 2005, Technometrics.
[43] D. Andrade,et al. Item response theory for longitudinal data: Item and population ability parameters estimation , 2006 .
[44] H. Earl,et al. Epirubicin and cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy for early breast cancer. , 2006, The New England journal of medicine.
[45] J. Verkuilen. Explanatory Item Response Models: A Generalized Linear and Nonlinear Approach by P. de Boeck and M. Wilson and Generalized Latent Variable Modeling: Multilevel, Longitudinal and Structural Equation Models by A. Skrondal and S. Rabe-Hesketh , 2006, Psychometrika.
[46] Ninds Net-Pd Investigators. A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease. , 2006 .
[47] R. Elble,et al. A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease , 2006, Neurology.
[48] David B Dunson,et al. Bayesian methods for latent trait modelling of longitudinal data , 2007, Statistical methods in medical research.
[49] J. Jankovic,et al. A randomized clinical trial of coenzyme Q10 and GPI-1485 in early Parkinson disease , 2007, Neurology.
[50] Peng Huang,et al. The Use of a Global Statistical Approach for the Design and Data Analysis of Clinical Trials with Multiple Primary Outcomes , 2008 .
[51] Peng Huang,et al. A rank‐based sample size method for multiple outcomes in clinical trials , 2008, Statistics in medicine.
[52] Joseph G. Ibrahim,et al. Missing data methods in longitudinal studies: a review , 2009 .
[53] Chunling Liu,et al. A Rank-Based Test for Comparison of Multidimensional Outcomes , 2010, Journal of the American Statistical Association.
[54] Jean-Paul Fox,et al. Bayesian Item Response Modeling , 2010 .
[55] John K Kruschke,et al. Bayesian data analysis. , 2010, Wiley interdisciplinary reviews. Cognitive science.
[56] J. Fox. Bayesian Item Response Modeling: Theory and Applications , 2010 .
[57] Gary King,et al. Amelia II: A Program for Missing Data , 2011 .
[58] Martyn Plummer,et al. JAGS Version 3.3.0 user manual , 2012 .
[59] P. O'Brien,et al. Global Assessment Variables , 2014 .
[60] Lena Osterhagen,et al. Multiple Imputation For Nonresponse In Surveys , 2016 .
[61] Marie Schmidt,et al. Nonparametrics Statistical Methods Based On Ranks , 2016 .